Newsweek columnist Peter Roff joins Gerry Rogers to expose the real reason behind America’s skyrocketing health care costs: the bloated, tax-exempt hospital monopolies gaming the nonprofit system. Roff argues that these billion-dollar hospital chains are exploiting their nonprofit status, lobbying government for favors, and passing the cost to everyday Americans — all while failing to deliver real charity care. This episode tackles the hidden economics of health care, tax reform, and the urgent need for transparency and accountability.

In this revealing episode of The Business of America, host Jerry Rogers speaks with Peter Pitts—former FDA official and president of the Center for Medicine in the Public Interest—about the hidden financial practices of nonprofit hospitals. They explore how tax breaks are misused, why hospitals escape scrutiny, and what real reform could look like at the state level. If you care about transparency, public health, or responsible spending, this conversation is essential listening.

On this episode of The Business of America podcast, host Jerry Rogers sits down with Kelly Ryan of Jesuit Refugee Services USA and Elizabeth Hoffman of the ONE Campaign to tackle the real-world impact of U.S. foreign aid. They expose the political missteps behind recent aid cuts, highlight bipartisan support for humanitarian programs, and explain why smart foreign investment isn’t charity—it’s national security, economic growth, and moral leadership. From faith-based arguments to hard-nosed geopolitics, this episode makes the American case for global engagement.

Dr. George Tidmarsh — physician, scientist, and biotech CEO — joins The Business of America podcast to reveal a shocking truth: talc, a substance linked to ovarian cancer, is still being used in common pharmaceuticals and food products. In this urgent conversation, Tidmarsh explains how the FDA's outdated "generally regarded as safe" (GRAS) list has gone unchecked since the 1970s. He makes the case for a complete overhaul of food and drug safety regulation — and calls for a return to honest, evolving science. From baby powder lawsuits to chronic disease epidemics, this episode lays bare the high cost of regulatory neglect — and what must be done now.

In this episode of the Business of America podcast, host Jerry Rogers sits down with Janet McUlsky, founder and CEO of McUlsky Health Force, to discuss her journey from Pfizer executive to health policy entrepreneur. Janet shares the origin story of her firm, launched at the height of the COVID-19 pandemic, and explains how she’s helping patient and consumer groups find their voice in the nation’s capital.

They cover critical topics like vaccine innovation, the complexity of Medicare, health insurance barriers, and how bipartisan dialogue can advance access to care. With decades of experience and a commitment to patient advocacy, Janet reveals how McUlsky Health Force is bridging the gap between industry, nonprofits, and policymakers to deliver better health outcomes for all.

📢 Learn how policy, prevention, and real conversations can shape the future of healthcare.

In this episode of Business of America, host Jerry Rogers dives into the murky world of Pharmacy Benefit Managers (PBMs) with two industry experts: Martha Nolan, Senior Policy Advisor at HealthyWomen, and Mike Stancil, VP of Strategic Alliances at AffirmedRx.

The conversation covers the real cost of prescription drugs, the hidden mechanics of the PBM industry, and how women disproportionately bear the burden of a confusing and costly healthcare system. Martha offers a patient-focused perspective shaped by years of advocacy, while Mike pulls back the curtain on rebate schemes, spread pricing, and how PBMs manipulate formularies for profit.

They also explore promising legislation, bipartisan reform efforts, and how transparent PBMs like AffirmedRx are changing the model to prioritize patients over profits.

🧠 Key Topics:

• What PBMs are and why they matter
• How rebate structures inflate drug prices
• Step therapy, prior authorizations, and their impact on women
• The role of HealthyWomen in healthcare education and policy
• What real PBM reform could look like

In this episode of The Business of America podcast, host Jerry Rogers sits down with Peter Pitts — former FDA Associate Commissioner and president of the Center for Medicine in the Public Interest — for a hard-hitting conversation on America’s drug pricing crisis and President Trump’s recent executive order introducing Most Favored Nation (MFN) pricing.

Pitts outlines why the executive order might backfire, what’s really driving high drug costs (hint: pharmacy benefit managers and insurance middlemen), and why reference pricing from Europe won’t fix America's access or innovation problems. They explore why reforms like 340B and market-based trade negotiations are more effective paths forward.

This episode cuts through the political noise with real policy insights on how to lower drug prices without sacrificing access or innovation.

In this episode of The Business of America podcast, host Jerry Rogers sits down with John Stanford, Managing Partner of the Prism Group, for a deep dive into the critical link between small business success and public health. From personal health stories to national policy, this conversation unpacks why preventive care—including vaccines and telemedicine—is essential for small business resilience.

John shares how his firm supports entrepreneurs across the U.S. and globally, and why small business leaders are some of the strongest advocates for innovative, affordable healthcare. If you're a policymaker, entrepreneur, or just passionate about America’s economic engine, this episode offers insight you won’t want to miss.

🔗 Learn more about Prism Group: www.prismgroup.global

🎧 Subscribe for more episodes: 
Spotify: www.open.spotify.com/show/6vSZ3mgA1JF0xobSsVx0li
Apple: www.podcasts.apple.com/us/podcast/the-business-of-america/id1711441228

📲 Follow The Business of America on social media for more updates.
Instagram: www.instagram.com/thebusinessofamerica/

Martin Kulldorff, Ph.D., Dr.h.c., is an epidemiologist, a biostatistician, and a founding fellow at Hillsdale College’s Academy for Science and Freedom. He has been a Professor of Medicine at Harvard University for thirteen years. Dr. Kulldorff’s research centers on developing and applying new disease surveillance methods for post-market drug and vaccine safety surveillance and for the early detection and monitoring of infectious disease outbreaks. In October 2020, he co-authored the Great Barrington Declaration, advocating for a pandemic strategy of focused protection instead of lockdowns.

Kevin Spivak is a highly regarded executive, entrepreneur, financier, author and attorney known for innovative leadership, sophisticated deal-making, understanding of financial markets and institutions, marketing expertise and “hands on” management. He is the founder, chairman and CEO of SMI Group LLC and chairman of its operating units.

Mr. Spivak has led multi-national companies with billions of dollars of worldwide sales and operations in more than 30 countries, including serving as CEO of a NewsCorporation affiliate, a wireless technology company and an investment banking firm, principal operating officer of major studio MGM/UA, founding chairman of the Paul Mitchell cosmetology schools and an officer and director of Merrill Lynch media and entertainment partnerships.

Mr. Spivak led, structured, negotiated and closed more than $10 billion of complex transactions, (more than $20 billion in current dollars), including acquisitions, dispositions, combinations, divestitures, financings, restructurings, licensing and other ventures. He led the development, financing, production, marketing and distribution of hundreds of feature films and television series grossing more than $3 billion ($7 billion in current dollars) and the branding, marketing and sales of consumer products and services grossing many additional billions of dollars. He has selected and distributed Academy Award®-winning films and long-running television series and launched successful consumer brands and pioneering technologies.